Why Clover Health Stock Fell in February

Shares of Clover Health Investments (NASDAQ: CLOV) fell 32.6% in February, according to data provided by S&P Global Market Intelligence, after the company was targeted by short-seller Hindenburg Research. Hindenburg called Clover Health "a broken company" and provided a good enough argument to cause some investors to walk away from the stock. Clover became public through one of the special purpose acquisition companies (SPACs) backed by billionaire investor Chamath Palihapitiya.